SELLAS Life Sciences Group Inc. SLS reported first-quarter (Q1) 2026 financial results on Tuesday while highlighting progress across its acute myeloid leukemia (AML) pipeline. CEO Angelos Stergiou ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results